Polaris Group (6550) fair value: what the stock is really worth
As of Nov 18, 2026: fair value (intrinsic value) of Polaris Group stock TWD 9.25, price TWD 12.85, that is 28.0% below the price, quality 36 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Polaris Group
6550 · TWExpensive (fair value 28% below the price) and weak company.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 11.05 TWD – 419.32 TWD · fair‑value band 6.93 TWD – 11.56 TWD · the 12.85 TWD price screens above the 9.25 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Polaris is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions.
Show moreShow less
The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands.
Stock analysis
Polaris Group (6550) currently trades at 12.85 TWD, while our estimate is 9.25 TWD, 28% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 6.93 TWD (bear) to 11.56 TWD (bull), the price of 12.85 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Polaris Group reported revenue of 40.6M TWD in FY2025 versus 15.0M TWD in FY2021, a compound +28.2%/yr. Reported net income was −3.9B TWD in FY2025.
Key figures
Market cap 6.2B TWD (≈ $187M) Micro · EPS (TTM) −9.05 TWD · Return on equity −81.1% · Return on assets (EBIT) −21.3% (5-year average) · Operating margin −7,429% · Revenue (TTM) 68.0M TWD · Revenue growth (YoY) −15.6% · Free cash flow −3.2B TWD.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (low confidence).
What moves the price
The share trades about 81% below its 52-week high and 16% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −6% fair-value upside, at −28%, 6550 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Polaris Group with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 849 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/B ratio by industry
- Net margin by industry
- Stock screener with 62 metrics
- Undervalued stocks: Taiwanese Stocks
- Valuation of the Taiwan market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $957.76 | $1,275 | +33% | vs 6550 |
| Samsung Biologics Co 207940 | 1,366,000 KRW | 1,552,100 KRW | +14% | vs 6550 |
| Vertex Pharmaceuticals Incorporated VRTX | $534.20 | $587.62 | +10% | vs 6550 |
| argenx SE ARGX | $947.52 | $908.40 | −4% | vs 6550 |
| CSL Limited CSL | A$199.38 | A$186.49 | −6% | vs 6550 |
| Moderna, Inc MRNA | $206.80 | $135.64 | −34% | vs 6550 |
| BeOne Medicines AG 6160 | HK$244.80 | HK$152.92 | −38% | vs 6550 |
| Revolution Medicines, Inc RVMD | $162.69 | $88.78 | −45% | vs 6550 |
| Celltrion, Inc 068270 | 207,500 KRW | 74,945 KRW | −64% | vs 6550 |
| Royalty Pharma plc RPRX | $68.68 | $19.01 | −72% | vs 6550 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Polaris Group (6550) overvalued or undervalued?
What is the fair value of 6550?
What is the quality score of 6550?
What is the price target for Polaris Group (6550)?
What is the Polaris Group stock forecast for 2026?
What is the revenue of Polaris Group (6550)?
What is the intrinsic value of Polaris Group (6550)?
Is Polaris Group stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 6550?
How much is Polaris Group worth?
What do the bullish and bearish scenarios say about 6550?
How solid is the balance sheet of Polaris Group (6550)?
How far is 6550 from its 52-week high?
Which stocks are comparable to Polaris Group?
Is Polaris Group stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Polaris Group (6550)?
What should I pay attention to with Polaris Group right now?
Key figures of Polaris Group
How large is the market capitalisation of Polaris Group (6550)?
What are the earnings per share of Polaris Group (6550)?
What is the return on equity of Polaris Group (6550)?
What is the EBIT return on assets of Polaris Group (6550)?
What is the operating margin of Polaris Group (6550)?
How fast is revenue growing at Polaris Group (6550)?
How much free cash flow does Polaris Group (6550) generate?
How much net debt does Polaris Group (6550) carry?
Watch Polaris Group in the live analysis
One click puts Polaris Group on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.